Jefferies Group's NAMS Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 122,728 shares of NewAmsterdam Pharma Company N.V. (NAMS) worth $4.16 M, representing 0.03% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Jefferies Group has maintained this position in NAMS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 122,728 shares. Largest reduction occurred in Q1 2026, reducing 12,000 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's NewAmsterdam Pharma Company NV (NAMS) Holding Value Over Time
Track share changes against reported price movement
Quarterly NewAmsterdam Pharma Company NV (NAMS) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +122,728 | New Buy | 122,728 | $33.89 |
| Q1 2026 | -12,000 | Sold Out | 0 | $0.00 |
| Q3 2025 | +12,000 | New Buy | 12,000 | $28.44 |
Jefferies Group's NewAmsterdam Pharma Company NV Investment FAQs
Jefferies Group first purchased NewAmsterdam Pharma Company N.V. (NAMS) in Q3 2025, acquiring 12,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held NewAmsterdam Pharma Company N.V. (NAMS) for 4 quarters since Q3 2025.
Jefferies Group's largest addition to NewAmsterdam Pharma Company N.V. (NAMS) was in Q2 2026, adding 122,728 shares worth $4.16 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 122,728 shares of NewAmsterdam Pharma Company N.V. (NAMS), valued at approximately $4.16 M.
As of the Q2 2026 filing, NewAmsterdam Pharma Company N.V. (NAMS) represents approximately 0.03% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in NewAmsterdam Pharma Company N.V. (NAMS) was 122,728 shares, as reported at the end of Q2 2026.